Gilead Earnings, Revenue beat In Q3

  • Investing.com
  • Stock Market News
Gilead Earnings, Revenue beat In Q3
Credit: © Reuters.

Investing.com - Gilead (NASDAQ: GILD ) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Gilead announced earnings per share of $2.65 on revenue of $7.42B. Analysts polled by Investing.com anticipated EPS of $1.74 on revenue of $6.25B.

Gilead shares are up 15% from the beginning of the year and are trading at $65.25 , down-from-52-week-high.They are under-performing the Nasdaq 100 which is up 22.42% from the start of the year.

Gilead shares lost 3.07% in after-hours trade the report.

Gilead follows other major Healthcare sector earnings this month

Gilead's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100